Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Definitive Healthcare (DH) Return on Sales (2020 - 2026)

Definitive Healthcare filings provide 6 years of Return on Sales readings, the most recent being 0.0% for Q4 2025.

  • On a quarterly basis, Return on Sales rose 1.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 2.0% increase, with the full-year FY2025 number at 0.01%, up 2.0% from a year prior.
  • Return on Sales hit 0.0% in Q4 2025 for Definitive Healthcare, up from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.0% in Q4 2022 to a low of 0.05% in Q2 2024.
  • Median Return on Sales over the past 5 years was 0.0% (2025), compared with a mean of 0.01%.
  • Biggest five-year swings in Return on Sales: decreased -5bps in 2024 and later rose 5bps in 2025.
  • Definitive Healthcare's Return on Sales stood at 0.0% in 2021, then skyrocketed by 130bps to 0.0% in 2022, then tumbled by -309bps to 0.0% in 2023, then plummeted by -571bps to 0.01% in 2024, then surged by 80bps to 0.0% in 2025.
  • The last three reported values for Return on Sales were 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025) per Business Quant data.